Insiders IDEAYA Biosciences, Inc.

Equities

IDYA

US45166A1025

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
36.6 ^USD	+2.26%		-2.94%	+2.87%

May. 28	IDEAYA Biosciences, Inc. Appoints Daniel A. Simon as Chief Business Officer, Effective August 2024	CI
May. 16	Ideaya Biosciences Insider Sold Shares Worth $7,397,291, According to a Recent SEC Filing	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IDEAYA Biosciences, Inc. Appoints Daniel A. Simon as Chief Business Officer, Effective August 2024	May. 28	CI
Ideaya Biosciences Insider Sold Shares Worth $7,397,291, According to a Recent SEC Filing	May. 16	MT
Ideaya Biosciences Insider Sold Shares Worth $4,495,550, According to a Recent SEC Filing	Feb. 12	MT
Ideaya Biosciences Insider Sold Shares Worth $350,371, According to a Recent SEC Filing	Dec. 19	MT
Ideaya Biosciences Insider Sold Shares Worth $2,627,618, According to a Recent SEC Filing	Dec. 19	MT
Ideaya Biosciences Insider Sold Shares Worth $155,360, According to a Recent SEC Filing	Nov. 07	MT
IDEAYA Biosciences Finance Chief Paul Stone Resigns	23-09-26	MT
IDEAYA Biosciences, Inc. Announces Resignation of Paul A. Stone as Chief Financial Officer	23-09-26	CI
Insider Sell: Ideaya Biosciences	23-07-12	MT
IDEAYA Biosciences, Inc. Appoints Andres Ruiz Briseno as Principal Accounting Officer	23-07-03	CI
IDEAYA Biosciences, Inc. Announces Board Appointments	22-12-19	CI
IDEAYA Biosciences Names Darrin Beaupre Chief Medical Officer	22-11-28	MT
IDEAYA Biosciences, Inc. Appoints Darrin M. Beaupre as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline	22-11-28	CI
IDEAYA Announces Development Candidate Nomination of a Potential First-in-Class Pol Theta Helicase Inhibitor in Collaboration with GSK	22-06-28	PR
IDEAYA Biosciences, Inc. Announces Development Candidate Nomination of Potential First-In-Class Pol Theta Helicase Inhibitor in Collaboration with GSK	22-06-28	CI
IDEAYA Biosciences, Inc. Appoints Catherine Mackey to its Board of Directors	22-04-06	CI
IDEAYA Biosciences Names Frank McCormick Chair of Scientific Advisory Board.	22-01-04	MT
IDEAYA Biosciences, Inc. Appoints Dr. Frank Mccormick as Chair of Scientific Advisory Board	22-01-04	CI
IDEAYA Biosciences : Names Michael White as Chief Scientific Officer	21-10-18	MT
IDEAYA Biosciences Appoints Michael White as Chief Scientific Officer	21-10-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders IDEAYA Biosciences, Inc.

Equities

IDYA

US45166A1025

Insiders

Filters